The use of FDG-PET scanning in lung cancer. Akciger kanserlerinde FDG-PET uygulamalari.
Tüberküloz ve toraks, cilt.53, sa.1, ss.95-114, 2005 (SCI-Expanded, Scopus, TRDizin)
- Yayın Türü: Makale / Derleme
- Cilt numarası: 53 Sayı: 1
- Basım Tarihi: 2005
- Dergi Adı: Tüberküloz ve toraks
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.95-114
- İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır
Özet
Positron emission tomography (PET) imaging with fluorodeoxyglucose (FDG) is a very useful imaging modality that significantly contributes to the diagnosis and staging in patients with lung cancer. Additionally, FDG-PET has been shown to play an effective role to predict therapy response and to assess tumor aggressiveness as well as to define radiotherapy treatment fields. Further technologic improvements in PET scanners and new more tumor specific radiopharmaceuticals are likely to bring further benefits to the management of patients with lung cancer in the future.